Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Clin Microbiol ; 48(9): 3438-9, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20631098

RESUMO

Yersinia enterocolitica rarely causes extraintestinal disease. A 54-year-old construction worker with chronic hepatitis C developed an axillary abscess following an injury to his finger. An aspirate from the axillary mass grew Y. enterocolitica. Direct inoculation is proposed as the mode of transmission of this classically enteric pathogen.


Assuntos
Abscesso/microbiologia , Axila/patologia , Traumatismos dos Dedos/complicações , Yersiniose/diagnóstico , Yersinia enterocolitica/isolamento & purificação , Abscesso/patologia , Axila/microbiologia , Hepatite C Crônica/complicações , Humanos , Masculino , Pessoa de Meia-Idade , Yersiniose/microbiologia , Yersiniose/patologia
2.
Infect Immun ; 74(12): 6847-54, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16954397

RESUMO

The human beta-defensin 3 (hBD-3) is an inducible epithelial peptide antibiotic that has potent antistaphylococcal activity. Infection of skin epithelial cells with viable Staphylococcus aureus, a common skin pathogen, induces increased gene expression of hBD-3 and other antimicrobial peptides. The aim of this study was to identify signaling pathways and nuclear responses that contribute to the gene expression of hBD-3 in primary human keratinocytes upon contact with S. aureus. Increased hBD-3 peptide was observed by immunofluorescence microscopy in keratinocytes exposed to S. aureus and to lipoteichoic acid (LTA). Both are ligands for the cell surface Toll-like receptor 2 (TLR2), and thus the contribution of TLR2 signaling in hBD-3 expression was examined. Functional inhibition of TLR2 prior to S. aureus stimulation significantly decreased hBD-3 mRNA levels by 37%, attesting to the involvement of this surface receptor in the initial recognition and downstream signaling for hBD-3 expression. Treatment of keratinocytes with a p38 mitogen-activated protein kinase (MAPK) inhibitor prior to either S. aureus or LTA stimulation was associated with reduced hBD-3 mRNA transcripts and peptide. We also propose a role for the MAPK-regulated transcriptional activating protein 1 in S. aureus-induced hBD-3 gene expression. Combined, these studies indicate a role for TLR2 signaling and MAPK activation in the upregulation of hBD-3 and demonstrate the innate immune capacity of skin keratinocytes under conditions of S. aureus challenge to enhance the local expression of this antistaphylococcal peptide antibiotic.


Assuntos
Queratinócitos/microbiologia , Staphylococcus aureus/fisiologia , Receptor 2 Toll-Like/fisiologia , beta-Defensinas/genética , Células Cultivadas , Expressão Gênica , Humanos , Queratinócitos/química , Queratinócitos/metabolismo , Lipopolissacarídeos/farmacologia , RNA Mensageiro/análise , RNA Mensageiro/metabolismo , Transdução de Sinais , Pele/citologia , Pele/metabolismo , Pele/microbiologia , Ácidos Teicoicos/farmacologia , Receptor 2 Toll-Like/agonistas , Receptor 2 Toll-Like/antagonistas & inibidores , Fator de Transcrição AP-1/metabolismo , Transcrição Gênica , beta-Defensinas/análise , beta-Defensinas/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/antagonistas & inibidores , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
3.
Infect Immun ; 73(8): 5241-4, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16041048

RESUMO

Keratinocytes upregulate expression of endogenous antimicrobial peptides in response to inflammatory stimuli. We show that both viable and heat-inactivated Staphylococcus aureus and lipoteichoic acid differentially alter expression of these peptides upon contact with human keratinocytes. The findings indicate a diversity of staphylococcal factors involved in upregulation of antimicrobial peptide expression in cutaneous epithelia.


Assuntos
Peptídeos Catiônicos Antimicrobianos/genética , Queratinócitos/microbiologia , Infecções Estafilocócicas/metabolismo , Staphylococcus aureus , Peptídeos Catiônicos Antimicrobianos/biossíntese , Epiderme/imunologia , Epiderme/metabolismo , Epiderme/microbiologia , Humanos , Queratinócitos/imunologia , Queratinócitos/metabolismo , Lipopolissacarídeos/metabolismo , Ácidos Teicoicos/metabolismo
4.
Curr Opin Infect Dis ; 16(3): 225-9, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12821812

RESUMO

PURPOSE OF REVIEW: Staphylococcus aureus produces two closely-related fibronectin-binding proteins (FnBPs) that facilitate attachment by this versatile pathogen. Recent studies of staphylococcal FnBP have increased our understanding of the molecular mechanisms that are critical in bacterial-host cell interactions and in infection. RECENT FINDINGS: This review will summarize current knowledge of the role of the FnBPs of Staphylococcus aureus in the pathogenesis of infection. The FnBPs, which facilitate attachment of this pathogen to host cells and to fibronectin-coated biomaterials, are important mediators of infection in experimental endocarditis. In addition, recent vaccine studies utilizing FnBP derivatives have shown partial protection in animals. FnBPs also act as invasins permitting uptake of the staphylococcus by cultured non-professional phagocytes using host fibronectin to bridge with integrins on the cell surface. However, the precise role of FnBP in tissue invasion and the relevance of intracellular invasion in disease remain to be elucidated. SUMMARY: FnBP is one of many adhesins expressed by S. aureus that influence host tissue adherence by binding to host fibronectin. FnBP-based vaccine strategies and novel anti-adherence tools based upon FnBP derivatives are in the early stages of investigation but may show promise in preventing staphylococcal infections.


Assuntos
Adesinas Bacterianas , Proteínas de Bactérias/fisiologia , Proteínas de Transporte/fisiologia , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/patogenicidade , Proteínas de Bactérias/química , Proteínas de Bactérias/metabolismo , Vacinas Bacterianas/imunologia , Proteínas de Transporte/química , Proteínas de Transporte/metabolismo , Modelos Biológicos , Infecções Estafilocócicas/imunologia , Staphylococcus aureus/imunologia , Fatores de Virulência/fisiologia
5.
J Infect Dis ; 185(7): 937-43, 2002 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-11920318

RESUMO

Adherence of Staphylococcus aureus to host tissues is a critical step for colonization and initiation of infection. The fibronectin-binding proteins (FnBPs) of S. aureus have been implicated in adherence and internalization in nonprofessional phagocytes. A recombinant fragment of the fibronectin-binding domains (rFnBF) that potently inhibits S. aureus entry into host cells was generated. To test the hypothesis that rFnBF may attenuate the establishment of infection, the ability of intermuscularly administered rFnBF to prevent abscess formation was determined in a guinea pig model of wound infection. rFnBF exhibited dose-dependent inhibition of abscess formation and, at a 100-microg dose, raised the median infective dose approximately 170-fold, compared with the control. In addition, rFnBF potentiated the benefit of prophylaxis with cefazolin. Thus, exogenous administration of the fibronectin-binding domain of FnBP reduces the risk of staphylococcal abscess formation and should be investigated further as a novel agent for prevention of wound infection.


Assuntos
Adesinas Bacterianas , Antibioticoprofilaxia , Proteínas de Bactérias/uso terapêutico , Proteínas de Transporte/uso terapêutico , Infecções Estafilocócicas/prevenção & controle , Staphylococcus aureus , Staphylococcus aureus/patogenicidade , Infecção dos Ferimentos/prevenção & controle , Animais , Proteínas de Bactérias/genética , Proteínas de Transporte/genética , Cefazolina/uso terapêutico , Células Cultivadas , Cefalosporinas/uso terapêutico , Modelos Animais de Doenças , Sinergismo Farmacológico , Endotélio Vascular/citologia , Endotélio Vascular/microbiologia , Feminino , Cobaias , Humanos , Masculino , Proteínas Recombinantes/genética , Proteínas Recombinantes/uso terapêutico , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/fisiologia , Veias Umbilicais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA